[go: up one dir, main page]

NO944680L - New thienothiazine derivatives, a process for their preparation and their use - Google Patents

New thienothiazine derivatives, a process for their preparation and their use

Info

Publication number
NO944680L
NO944680L NO944680A NO944680A NO944680L NO 944680 L NO944680 L NO 944680L NO 944680 A NO944680 A NO 944680A NO 944680 A NO944680 A NO 944680A NO 944680 L NO944680 L NO 944680L
Authority
NO
Norway
Prior art keywords
preparation
halogen
new
thienothiazine derivatives
thienothiazine
Prior art date
Application number
NO944680A
Other languages
Norwegian (no)
Other versions
NO944680D0 (en
Inventor
Dieter Binder
Josef Weinberger
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of NO944680D0 publication Critical patent/NO944680D0/en
Publication of NO944680L publication Critical patent/NO944680L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er beskrevet tienotlazlnderlvater med formel (I) (D hvori X betyr en enkeltblnding eller en 5 - 12-leddet, mono- eller polycykllsk, eventuelt delvis hydrert aryl- eller heteroarylrest som eventuelt kan være substituert med halogen, laverealkyl eller laverealkoksy, Y betyr en enkeltbindlng eller et heteroatom, R betyr en mono- eller polycyklisk, eventuelt delvis hydrert 5 - 12-leddet aryl- eller heteroarylrest som eventuelt kan være substituert en eller flere ganger med halogen, laverealkyl eller laverealkoksy, A betyr halogen, og B betyr hydrogen eller halogen. Det er videre beskrevet en fremgangsmåte for fremstilling av forbindelsene samt deres anvendelse som farmasøy-tika.Thienothiazol substituents of formula (I) (D) are disclosed in which a single bond or a heteroatom, R means a mono- or polycyclic, optionally partially hydrated 5-12 membered aryl or heteroaryl radical which may or may not be substituted one or more times by halogen, lower alkyl or lower alkoxy, A means halogen, and B means hydrogen or a halogen A process for the preparation of the compounds as well as their use as pharmaceuticals is further described.

NO944680A 1993-12-06 1994-12-05 New thienothiazine derivatives, a process for their preparation and their use NO944680L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0246193A AT400845B (en) 1993-12-06 1993-12-06 NEW THIENOTHIAZINE DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND THEIR USE

Publications (2)

Publication Number Publication Date
NO944680D0 NO944680D0 (en) 1994-12-05
NO944680L true NO944680L (en) 1995-06-07

Family

ID=3534780

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944680A NO944680L (en) 1993-12-06 1994-12-05 New thienothiazine derivatives, a process for their preparation and their use

Country Status (6)

Country Link
EP (1) EP0657459A1 (en)
JP (1) JPH07252260A (en)
CN (1) CN1111634A (en)
AT (1) AT400845B (en)
CA (1) CA2137443A1 (en)
NO (1) NO944680L (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19632556A1 (en) 1996-08-13 1998-02-19 Bayer Ag Process for the production of high-rubber ABS molding compounds
US20010049379A1 (en) 1997-08-27 2001-12-06 Lowe John Adams 2-aminopyridines containing fused ring substituents
HN1998000118A (en) * 1997-08-27 1999-02-09 Pfizer Prod Inc 2 - AMINOPYRIDINES CONTAINING SUBSTITUTES FOR CONDENSED RINGS.
BR112013006272A2 (en) 2010-09-17 2019-09-24 Purdue Pharma Lp pyridine compounds and their uses
US9656959B2 (en) * 2010-12-22 2017-05-23 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
TWI644899B (en) 2013-02-04 2018-12-21 健生藥品公司 Flap modulators
JP6424173B2 (en) 2013-02-04 2018-11-14 ヤンセン ファーマシューティカ エヌ.ベー. FLAP regulator
CN111646987B (en) * 2020-06-05 2022-06-24 湖南师范大学 5-aminothiazole non-steroidal anti-inflammatory compound and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE69027594T2 (en) * 1989-11-30 1996-10-31 Nippon Hypox Lab Inc A MEDICINE CONTAINING THIAZINE DIOXIDE DERIVATIVE
AT399880B (en) * 1992-07-03 1995-08-25 Chem Pharm Forsch Gmbh NEW THIENOTHIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Also Published As

Publication number Publication date
CA2137443A1 (en) 1995-06-07
CN1111634A (en) 1995-11-15
EP0657459A1 (en) 1995-06-14
JPH07252260A (en) 1995-10-03
NO944680D0 (en) 1994-12-05
AT400845B (en) 1996-03-25
ATA246193A (en) 1995-08-15

Similar Documents

Publication Publication Date Title
NO944700L (en) New Thienothiazine Derivatives, Process for their Preparation and Pharmaceutical Preparations Containing the Compounds
KR900700486A (en) New benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of preparation and use
AU7186494A (en) Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
CA2161542A1 (en) Novel 5-Pyrrolyl-2-Pyridylmethylsulfinyl Benzimidazole Derivatives
NO20004121L (en) New compounds and their use as positive AMPA receptor modulators
NO940550L (en)
NO303780B1 (en) New 4-arylpiperazines and 4-arylpiperidines, composition containing them and their use in the manufacture of therapeutics
NO20022558L (en) 4-Carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor
DK0923554T3 (en) N-Benzylpiperidine and tetrahydropyridine derivatives
NO986180L (en) Novel amidino derivatives and their use as thrombin inhibitors
NO971625L (en) Novel peptides with immunomodulatory effects
IE40598B1 (en) Piperidine derivatives
FI925415A0 (en) FRAMSTAELLNING AV SUBSTITUERADE PIPERIDINER
NO911158L (en) Hydantoin derivatives.
NO944680L (en) New thienothiazine derivatives, a process for their preparation and their use
NO941958D0 (en) Preparation of substituted piperidines
NO971142L (en) Bis- (2-haloethyl) aminophenyl-substituted distamycin derivatives as antitumor and antiviral agents
NO922114L (en) CHEMICAL CONNECTIONS
NO953892L (en) Imidazoloquinoxalinone derivatives as EAA antagonists
NO933837L (en) 4-aryl-3- (heteroarylureido) quinoline derivatives
NO904135L (en) PROCEDURE FOR THE PREPARATION OF NEW SUBSTITUTED ALKYL PIPERIDINES AND THEIR USE AS INHIBITORS OF CHOLESTEROL SYNTHESIS.
NO932129L (en) Procedure for the Preparation and Use of New Thienothiazine Derivatives
YU3099A (en) Novel erythromycine derivatives, procedure for production and application thereof
NO971424L (en) Novel heterocyclic substituted imidazoloquinoxalinones, their preparation and use
DK0432841T3 (en) Spiro-indoline-oxazine compounds with photochromatic and photosensitizing properties and process for their preparation